Drizalma sprinkle approval 2019?

Drizalma Sprinkle's approval date in 2019 is not directly available in the provided information. However, Drizalma is an oral liquid formulation of diclofenac used to treat pain in patients 23 months of age and older. It was developed by Acura Pharmaceuticals. [1]

What is Drizalma Sprinkle used for?

Drizalma Sprinkle is indicated for the relief of mild to moderate pain in patients 23 months of age and older. It is an oral liquid formulation of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID). [1]

Who makes Drizalma Sprinkle?

Drizalma Sprinkle was developed by Acura Pharmaceuticals. [1]

What is the active ingredient in Drizalma Sprinkle?

The active ingredient in Drizalma Sprinkle is diclofenac. [1]

How does Drizalma Sprinkle work?

Drizalma Sprinkle is an NSAID that works by inhibiting cyclooxygenase (COX) enzymes, which are involved in the synthesis of prostaglandins. Prostaglandins are mediators of inflammation, pain, and fever. By reducing prostaglandin production, diclofenac helps to alleviate pain and inflammation. [1]